Surveys at a Glance

Please cite all information retrieved from the Gateway data as follows:
Gateway to Global Aging Data, Produced by the Program on Global Aging, Health & Policy, University of Southern California with funding from the National Institute on Aging (R01 AG030153)
HRS MHAS ELSA SHARE CRELES KLoSA JSTAR TILDA CHARLS LASI
United States Mexico England 20+ European countries & Israel Costa Rica Korea Japan Ireland China India
STUDY OVERVIEW HRS MHAS ELSA SHARE CRELES KLoSA JSTAR TILDA CHARLS LASI
Respondent Eligibility
Age Eligibility 51 50 50 50 Cohort 1: 60 / Cohort 2: 55-65 45 50-75 50 45 45
One or all age-eligible one one all one† one all one all one all
Spouse inclusion regardless of age regardless of age regardless of age regardless of age Cohort 1: none / Cohort 2: regardless of age only if age eligible none regardless of age regardless of age regardless of age
Survey
Method in-person/ phone/ self-completion in-person in-person/self-completion in-person/self-completion in-person in-person in-person/self-completion in-person/self-completion in-person in-person
Sample refreshment
Waves or frequency every 3 waves Wave 5 Waves 3, 4, 6, 7 Waves 2, 4, 5, 6, 7 none Wave 5 none none none none
Sample Size
At baseline 12,600 15,200 12,000 30,700 Cohort 1: 2,800 / Cohort 2: 2,700 10,200 3,700 8,500 17,700 1,600
At latest released wave 20,900 16,000 8,400 76,500 Cohort 1: 1,800 / Cohort 2: 2,400 7,400 5,100 5,700 21,000 1,600
Blood-based biomarker
Type dbs venous and dbs venous dbs venous none none venous venous dbs
dbs: dried blood spots.
The original Wave 1 sample of SHARE interviewed all age-eligible individuals in a household.
* Not all collected waves have been released
HRS MHAS ELSA SHARE KLoSA JSTAR TILDA CHARLS LASI
United States Mexico England 20+ European countries & Israel Korea Japan Ireland China India
1992-93
1994-95
1996-97
1998-99
2000-01 MHAS W1 Anthropometric Measures
2002-03 MHAS W2 Anthropometric Measures ELSA W1 Timed Walk
2004-05 HRS W7 Physical Measures ELSA W2 Timed Walk
ELSA W2 Nurse Visit
SHARE W1 Walking Speed
SHARE W1 Grip Strength
2006-07 HRS W8 Physical Measures ELSA W3 Timed Walk SHARE W2 Walking Speed
SHARE W2 Grip Strength
SHARE W2 Peak Flow
SHARE W2 Chair Stand
KLoSA W1 Grip Strength JSTAR W1 Grip Strength
2008-09 HRS W9 Physical Measures ELSA W4 Timed Walk
ELSA W4 Nurse Visit
SHARELIFE Grip Strength KLoSA W2 Grip Strength JSTAR W2: 2 Cities Grip Strength
JSTAR W2: 5 Cities Grip Strength
CHARLS Pilot Biomarker
2010-11 HRS W10 Physical Measures ELSA W5 Timed Walk SHARE W4 Grip Strength
SHARE W4 Peak Flow
KLoSA W3 Grip Strength JSTAR W3: 3 Cities Grip Strength
JSTAR W3: 7 Cities Grip Strength
TILDA W1 Health Assessment CHARLS Biomarker 2011 LASI Pilot Biomarker
2012-13 HRS W11 Physical Measures MHAS W3 Anthropometric Measures ELSA W6 Timed Walk
ELSA W6 Nurse Visit
SHARE W5 Grip Strength
SHARE W5 Chair Stand
KLoSA W4 Grip Strength TILDA W2 Grip Strength
TILDA W2 Timed up and go
CHARLS Biomarker 2013
2014-15 HRS W12 Physical Measures ELSA W7 Timed Walk SHARE W6 Grip Strength
SHARE W6 Peak Flow
KLoSA W5 Grip Strength TILDA W3 Health Assessment CHARLS Biomarker 2015
2016-17 HRS W13 Physical Measures ELSA W8 Timed Walk
ELSA W8 Nurse Visit
SHARE W7 Grip Strength LASI W1 Biomarker
2018-19
All Surveys
LASI-DAD HRS-HCAP Mex-Cog ELSA-HCAP Chile-Cog
India United States Mexico United Kingdom Chile
2018-19 Informant W1 Cognition W1
Informant W1
Informant W1 Informant W1 Informant W1
All Surveys Harmonized DAD Coming Soon Coming Soon Coming Soon Coming Soon